Implantable Cardioverter Defibrillator (ICD Registry)



Status:Recruiting
Conditions:Cardiology, Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:6/29/2017
Start Date:June 2005
End Date:June 2030
Contact:NCDR Product Support
Email:ncdr@acc.org
Phone:1-800-257-4737

Use our guide to learn which trials are right for you!

The ICD Registry™ is a nationwide quality program that helps participating hospitals measure
and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and
cardiac resynchronization therapy devices with defibrillator (CRT-Ds). The ICD Registry
captures the characteristics, treatments, and outcomes of patients receiving (ICDs).
Patient-level data is submitted by participating hospitals on a quarterly basis to the
American College of Cardiology Foundation's (ACCF) National Cardiovascular Data Registry
(NCDR) which then produces an Outcomes Report of the hospital's data, with comparison to
both a volume peer group (number of ICD patients submitted annually) and the entire ICD
registry data set.

In January 2005 the Centers for Medicare and Medicaid Services (CMS) expanded the covered
indications for primary prevention implantable cardioverter defibrillators (ICDs) to
incorporate the findings from the Sudden Cardiac Death Heart Failure Trial (SCDHeFT) and the
Multicenter Automatic Defibrillator Implantation Trial II (MADIT II). As part of this
expansion, CMS mandated that a national registry be formed to compile data on Medicare
patients implanted with primary prevention ICDs to confirm the appropriateness of ICD
utilization in this patient population.

Responding to this mandate, a collaborative effort of the Heart Rhythm Society (HRS)and the
American College of Cardiology Foundation (ACCF), utilizing the expertise of the National
Cardiovascular Data Registry (NCDR®), developed the ICD Registry™. Enrollment opened on June
1, 2005. CMS selected the NCDR ICD Registry as the mandated national registry in October
2005.

All U.S and International patients.

Inclusion Criteria:

- All patients who receive an ICD/CRT-D (initial or generator change) for primary or
secondary prevention purposes.

- All patients with an ICD/CRT-D undergoing a Lead Only procedure.

- U.S. populations must submit all patients who receive an ICD/CRT-D (initial or
generator change) for primary prevention purposes who are insured by Medicare.

Exclusion Criteria:
We found this trial at
1
site
2400 N Street Northwest
Washington, D.C., District of Columbia 20037
Phone: 800-257-4737
?
mi
from
Washington, D.C.,
Click here to add this to my saved trials